This large analysis compared survival outcomes between postoperative CRT and RT alone in patients undergoing resection of high-risk major SGCs using a nationally representative database. The addition of concurrent chemotherapy to RT in patients with high-risk major SGCs did not offer an advantage in OS.
No takes yet. Share an insight, caveat, or question.
Amini et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: